Skip to main content

Growing Economic Burden of Chronic Diseases Paving the Way for Precision Medicine Market

 

Rising economic burden of chronic diseases is considered to be one of the significant challenges that healthcare and biomedical research and development systems are facing at present. The high prevalence of chronic diseases, such as cancer, diabetes, cardiovascular diseases, and respiratory diseases, among others, is a prime concern across the globe. The chronic diseases have been responsible for 60% of the deaths worldwide and constitute approximately 43% of the global economic burden for diseases. According to World Health Organization in 2016, healthcare spending increased from 2.4% to 7.5% between 2015 and 2020.By 2020, the global spending on diseases, such as cardiovascular diseases, cancer, and respiratory diseases, is expected to reach $4 trillion. The chronic conditions hold approximately 65% of the annual healthcare cost of any country and one-third of the global population at present. Figure3: Chronic Conditions: Key Statistics Source: WHO Website, Deloitte 2016 Survey of U.S. Health Care Consumers, and BIS Research Analysis Chronic Conditions: Key Statistics1/3rdof the Global Population Approximately 65% of the country’s annual health care costs$4 Trillion Economic Loss Due to Chronic Conditions By 2020CancerCardiovascularMetabolic Conditions Others Precision Medicine Potential $200 Billion Savings from Chronic Conditions by 2025

 

The growth of the precision medicine market over the last few years have been monumental. The factors propelling the growth of the precision medicine market are increasing focus on targeted therapy by reducing trial-and-error medicine, growing demand for non-invasive testing procedures, reducing adverse  drug  reactions  through  pharmacogenomics  testing,  advancement  of  technology  in understanding human biology & disease susceptibility, and shift in the significance of medicine from reaction to prevention, among others. However, several clinical, economic, ethical, and regulatory conditions continue to challenge the growth of the market.

Labels:

Comments

Post a Comment

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...
2 comments
Read more

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...
1 comment
Read more

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...
1 comment
Read more